Randomized, double-blind, placebo-controlled, safety, tolerability, PK, PD and exploratory efficacy phase 1b/2a trial with AC01 in patients with HFrEF
10 May 2026 (15:42 - 15:54)
Organised by: 
Slides
About the speaker
Karolinska University Hospital, Stockholm (Sweden)
4 More presentations in this session
Professor R. Baptista (Santa Maria da Feira, PT)
Professor O. Chioncel (Bucharest, RO)
Professor E. Wright (Danville, US)
Professor C. Lam (Singapore, SG)
Access the full session
The Event
Heart Failure 2026
10 May 2026
15:42 CET
You may be interested in
Congress Session
Congress Session
